Older adults with COVID-19 commonly present to the ED with delirium
Delirium in Older Patients With COVID-19 Presenting to the Emergency Department – JAMA Network Open Commentaries: Delirium could signal Covid-19 infection in older adults, study finds – STAT AND Delirium fairly common in older COVID-19 patients – CIDRAP AND Delirium is first symptom for many elderly COVID-19 patients – UPI Commentary on Twitter In […]
The post Older adults with COVID-19 commonly present to the ED with delirium appeared first on Links Medicus.
Randomized trial suggesting mask use does not protect the wearer from Covid-19 sparks controversy
Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial – Annals of Internal Medicine Editorials: Of Masks and Methods AND The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the Puzzle Commentaries: Expert reaction to paper using an […]
The post Randomized trial suggesting mask use does not protect the wearer from Covid-19 sparks controversy appeared first on Links Medicus.
Phase 2 trial of Oxford COVID-19 vaccine finds it is safe and provokes immune response in young as well as in older adults
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial Commentaries: Covid: Oxford vaccine shows ‘encouraging’ immune response in older adults – BBC AND Age and frailty in COVID-19 vaccine development – The Lancet AND Expert reaction to phase 2 […]
The post Phase 2 trial of Oxford COVID-19 vaccine finds it is safe and provokes immune response in young as well as in older adults appeared first on Links Medicus.
Updated WHO guideline on drugs for Covid-19 rejects Remdesivir and strongly recommends Corticosteroids for patients with severe and critical disease
A living WHO guideline on drugs for covid-19 – The BMJ Commentary: WHO Guideline Development Group advises against use of remdesivir for COVID-19 – British Medical Journal Commentary on Twitter Today the @WHO rejects Remdesivir for #COVID19.The same drug the @US_FDA gave a full approval.Because the @WHO reviewed all the data and made the […]
The post Updated WHO guideline on drugs for Covid-19 rejects Remdesivir and strongly recommends Corticosteroids for patients with severe and critical disease appeared first on Links Medicus.
Review: Fluid administration and monitoring in ARDS. Restrictive vs. liberal strategy of fluid administration, assessment of fluid responsiveness, and other topics are discussed
Fluid administration and monitoring in ARDS: which management? – Intensive Care Medicine Commentary on Twitter Fluid administration & monitoring in #ARDS:➡️ pathophysiology➡️ fluid therapy➡️ fluid balance & outcome➡️ restrictive vs liberal strategy?➡️ assessing responsiveness➡️ origin of positive balance & correction➡️ approach according to ARDS cause/timinghttps://t.co/wIt305B1Ci pic.twitter.com/54whmo7OmC — Intens Care Med (@yourICM) November 12, 2020 […]
The post Review: Fluid administration and monitoring in ARDS. Restrictive vs. liberal strategy of fluid administration, assessment of fluid responsiveness, and other topics are discussed appeared first on Links Medicus.
More people are getting COVID-19 twice, suggesting immunity wanes quickly in some
More people are getting COVID-19 twice, suggesting immunity wanes quickly in some – Science
The post More people are getting COVID-19 twice, suggesting immunity wanes quickly in some appeared first on Links Medicus.
Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy
Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy – STAT News release: Pfizer and Biontech conclude phase 3 study of Covid-19 vaccine candidate, meeting all primary efficacy endpoints Commentaries: ‘Incredible milestone for science.’ Pfizer and BioNTech update their promising COVID-19 vaccine result – Science AND Pfizer: COVID-19 […]
The post Pfizer and BioNTech to submit Covid-19 vaccine data to FDA as full results show 95% efficacy appeared first on Links Medicus.
ATS Guideline: Home oxygen therapy for adults with chronic lung disease
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline – American Journal of Respiratory and Critical Care Medicine Commentary: Home Oxygen Therapy for Adults with COPD and ILD: New ATS Clinical Practice Guideline – American Thoracic Society
The post ATS Guideline: Home oxygen therapy for adults with chronic lung disease appeared first on Links Medicus.
Chinese Covid-19 vaccine candidate (CoronaVac) appears safe and induces an immune response in healthy volunteers in phase 1/2 clinical trial
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial – The Lancet Commentaries: Covid-19: Chinese vaccine ‘successful in mid-stage trials’ – BBC AND Expecting the unexpected with COVID-19 vaccines – The Lancet Infectious Diseases Commentary on Twitter NEW—Chinese #COVID19 vaccine […]
The post Chinese Covid-19 vaccine candidate (CoronaVac) appears safe and induces an immune response in healthy volunteers in phase 1/2 clinical trial appeared first on Links Medicus.
[Preprint] Study suggests immunity to the Coronavirus may last years
Immunological memory to SARS-CoV-2 assessed for greater than six months after infection – bioRxiv Commentaries: Immunity to the Coronavirus May Last Years, New Data Hint – New York Times AND Could coronavirus immunity last YEARS? Study finds even survivors who had mild COVID-19 are protected for at least 8 months and their immune ‘memory’ may […]
The post [Preprint] Study suggests immunity to the Coronavirus may last years appeared first on Links Medicus.